The authors wish to make a correction to the published version of their paper \[[@B1-nutrients-12-01266]\].

Unfortunately, we noticed a mistake regarding the description of the bioactive dipeptide in our paper. Instead of "arginine--proline (AP)" the correct amino acid dipeptide is "alanine--proline (AP)". In the published version of our paper \[[@B1-nutrients-12-01266]\], this affects two positions, namely:Page 2 of 16: "We used Pep2Dia^®^ as an investigational product containing a bioactive alanine--proline (AP) dipeptide with alpha-glucosidase inhibiting properties".Page 4 of 16: "2.3 Intervention/ The investigational product (Pep2Dia^®^) was a milk protein hydrolysate from native whey protein containing a bioactive alanine--proline (AP) dipeptide (between 0.15% and 0.4%) with alpha-glucosidase inhibiting properties."

The authors apologize to the readers for any inconvenience caused by the change. This change does not impact the content of the paper, the overall results or scientific conclusions. The original manuscript will remain online on the article webpage, with a reference to this correction.

The authors would like to thank all subjects who took part in this clinical trial.
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